Global /United Kingdom /Healthcare /Drug Manufacturers - Specialty & Generic /GUN
chevron_leftBack
Gunsynd Plc logo

Gunsynd Plc

GUN
LSE: GUN Delayed
0.0911GBX -3.6%
0.0012 USD
As of 6 June 2026, Gunsynd Plc has a market cap of $1.86M USD, ranking #47335 globally and #1094 in the United Kingdom. It ranks #4201 in the Healthcare sector, and #323 in the Drug Manufacturers - Specialty & Generic industry.
Global Rank
47335
Country Rank
1094
Sector Rank
4201
Industry Rank
323
Key Stats
Market Cap
$1.86MUSD
1.39M GBP
Enterprise Value
$1.1MUSD
824.06K GBP
Revenue (TTM)
$1.79MUSD
1.34M GBP
Net Income (TTM)
$743.74KUSD
554.0K GBP
Profit Margin
41%
PE Ratio
2.4
PS Ratio
1.0
PB Ratio
0.5
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1
Founded
2005
Website
gunsynd.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-3.6% -13% -8.9% -22% -34% -33%

News

Loading...

Markets

Exchange Ticker Price
London Stock Exchange
MIC: XLON
PRIMARY
GUN
Gunsynd PLC
ISIN: GB00BMD6PM55
Shares Out.:
1.476B1 Shares Float: 1.343B2
TV:
SA:
YF:
GF:
BA:
GUN
MS:
0.0911 GBX
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Gunsynd Plc

Gunsynd Plc is a private equity firm that specializes in buyout and project investments. The firm may make investments in all types of assets and there will be no investment restrictions on the type of investment that the company might make or the type of opportunity that may be considered. The firm primarily invests in the natural resources sector, life sciences sector with a focus on plant-based nutrition and environmentally friendly food alternatives, and the alcohol beverage sector, particularly in ingredients like sugar cane, agave, and molasses. It seeks to invest specifically in Europe Australia, the US, and the Caribbean; however, it can consider investments in other regions if they are profitable by the board. The Firm may take any possible opportunity in the world. It also specializes in direct acquisitions, farm-ins, partnerships; earn – in joint ventures, debt of other loan structures, joint ventures direct or indirect interests in assets of projects. The firm might seek both minority and majority stake position in its investments and can indulge in multiple investments. The average holding period of the firm’s investments is generally for medium-to-long-term, however it can also dispose its assets if there is an opportunity to make shareholders value. The firm may be active of passive investor depending upon the situation. The firm was formerly known as Evocutis plc and changed its name to Gunsynd Plc in August 2016. Gunsynd Plc was founded on 16 December 2005 and is based in London, the United Kingdom.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (United Kingdom)
Name
Market Cap diff.
PE
$4.01B
2.98B GBP
215K%
10.3
$875.65M
652.25M GBP
47K%
-
$721.59M
537.5M GBP
39K%
19.5
$308.67M
229.92M GBP
16K%
73.8
IMM
$35.18M
26.2M GBP
2K%
-
PXS
$32.28M
24.05M GBP
2K%
-
Industry: Drug Manufacturers - Specialty & Generic (Global)
Name
Market Cap diff.
PE
$37.66B
108.92B ILS
2M%
24.2
$29.56B
2M%
-
$15.86B
107.34B CNY
851K%
16.0
CIPLA
$11.12B
1.06T INR
597K%
23.4
LUPIN
$11.0B
1.05T INR
591K%
22.7
$9.1B
61.6B CNY
489K%
80.6
chevron_leftBack